OM1, Inc. – Trademark Portfolio
Entity Type: 03
OM1, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include OM1, OMBI, PHENOM, and OM1 HEALTH. The owner is based in Boston, MA.
31 St. James Avenue, Suite 1125
Boston, MA 02116
Showing of trademarks Trademarks
Trademark Classifications
OM1, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does OM1, Inc. have?
OM1, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does OM1, Inc. file in?
OM1, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are OM1, Inc.'s most well-known trademarks?
OM1, Inc.'s registered trademark portfolio includes well-known marks such as OM1, OMBI, PHENOM, and OM1 HEALTH. These are among 5 currently registered trademarks in the portfolio.
What is OM1, Inc.'s trademark registration success rate?
OM1, Inc. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.